Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICTORIA: Vinflunine + Gemcitabine vs Paclitaxel + Gemcitabine in Advanced Breast Cancer
NCT02054338Phase 3Terminated
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jun 2006
- Primary completion
- Jun 2011
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 3 trial of vinflunine in breast cancer, sponsored by Pierre Fabre Laboratories. Started Jun 2006; status: terminated.
02
Drugs
vinflunine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02054338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054338.